China drafts new rule to improve management of outbound investment

BEIJING, Nov. 3 (Xinhua) — China’s top regulatory changes economic planner Friday released a new draft rule to simplify administrative procedures and strengthen regulation on outbound investment by Chinese firms…
READ MORE >>

Chinese Government Initiates Significant Drug and Device Regulatory Reforms

China has recently announced several initiatives to reform its regulation of drugs and medical devices that could …
READ MORE >>

China’s NDRC seeks public comments on important outbound investment regulatory changes

On 3 November 2017, the National Development and Reform Commission (“NDRC”), one of China’s key outbound…
READ MORE >>

As National Party Congress concludes, China’s FDA seeks to write widely-anticipated drug reforms into law

In a bid to move Chinese drug industry regulations closer to the US/European model, …
READ MORE >>

Excellence in Medical Affair: Recent trends in China Medical Affairs and Outcomes from China Medical Affairs Survey 2016

Excellence in Medical Affair: Recent trends in China Medical Affairs and Outcomes from China Medical Affairs Survey 2016″ is developed by Deloitte..
READ MORE >>

China’s changing pharmaceutical E-commerce market

“China’s changing pharmaceutical E- commerce market” is developed by Deloitte China Life Sciences and Health Care Industry, Technology, Media & Telecommunications Industry…
READ MORE >>